Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-18-063301

President & CEO acquired 68,450 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
ROBIN HOWARD W President & CEO 2018-12-14 Grant or award +68,450 317,591 D
Derivatives
ROBIN HOWARD W President & CEO 2018-12-14 Grant or award · Stock Option +138,350 138,350 D
Loading xslF345X03/doc4.xml…